Subcategory & Sub-subcategory
Specifications
- Expression System: Recombinant mammalian (CHO) cell line expression, optimized for high-titer productivity
- Purity: High analytical comparability to reference product, consistent with mAb purity standards (typically ≥95% monomer by SEC-HPLC)
- Formulation Type: Liquid formulation intended for subcutaneous injection, humanized IgG2 monoclonal antibody
- Storage Condition: Store refrigerated at 2-8°C, protect from light; do not freeze
- Regulatory Status: Developed from a cell line with DMF filing in place, supporting global regulatory submissions; reference product (Ajovy) approved by FDA on 2018-09-14
- Application: CGRP antagonist monoclonal antibody for the preventive treatment of migraine in adults
Leave your rating & comment